3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Sleep Wake Disorders
2
Colorectal Neoplasms
2
Colonic Neoplasms
2
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Tobacco Use Disorder
1
Tobacco Smoking
1
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Prostate Adenocarcinoma
1
Postoperative Complications
1
Pancreatic Neoplasms
1
Oropharyngeal Neoplasms
1
Neoplasm Metastasis
1
Nasopharyngeal Neoplasms
1
Mouth Neoplasms
1
Lung Neoplasms
1
Liver Neoplasms
1
Leukemia, Myeloid, Acute
1
Leukemia
1
Laryngeal Neoplasms
1
Kidney Neoplasms
1
Hypopharyngeal Neoplasms
1
Hematologic Neoplasms
1
Head and Neck Neoplasms
1
Fatigue
1
Esophageal Neoplasms
1
Depression
1
Interventions
Gemcitabine
4
pembrolizumab
2
Leucovorin
2
Irinotecan
2
Fluorouracil
2
Albumin-Bound Paclitaxel
2
4-fluorobenzoyl-TN-14003
2
regorafenib
1
olaparib
1
irinotecan sucrosofate
1
ibrutinib
1
adavosertib
1
Paclitaxel
1
PEGPH20
1
Oxaliplatin
1
Drug Therapy
1
Docetaxel
1
Cisplatin
1
Capecitabine
1
BKT140
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Metastatic Pancreatic Adenocarcinoma
×
Counseling
×
Clear all
No trials found.